Transition metal complexes of buparvaquone as potent new antimalarial agents: 1. Synthesis, X-ray crystal-structures, electrochemistry and antimalarial activity against Plasmodium falciparum

Journal of Inorganic Biochemistry

Volumn 95, Issue 4, 2003, Pages 249-258

  Gokhale, Nikhil H ^a   Padhye, Subhash B ^a   Croft, Simon L ^b   Kendrick, Howard D ^b   Davies, Wendy ^b   Anson, Christopher E ^c   Powell, Annie K ^c  

^a UNIVERSITY OF PUNE   (India)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF KARLSRUHE   (Germany)

Author keywords

Antimalarial; Buparvaquone; Copper; Electrochemistry

Indexed keywords

BUPARVAQUONE; CHLOROQUINE; COBALT COMPLEX; COPPER COMPLEX; MANGANESE DERIVATIVE; METAL COMPLEX; NICKEL COMPLEX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMALARIAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTROCHEMICAL ANALYSIS; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; PLASMODIUM FALCIPARUM; STRUCTURE ACTIVITY RELATION; X RAY CRYSTALLOGRAPHY;

PLASMODIUM FALCIPARUM;

EID: 0038799864     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-0134(03)00134-X     Document Type: Article

References (38)

1. Lemke T.L. Antiparasitic agents. Williams D.A., Lemke T.L. Foye's Principles of Medicinal Chemistry. 5th Edition:2002;867-890 Lippincott Williams and Wilkins, New York. Chapter 35.
2. http://www.who.int/inf-fs/en/InformationSheet01.pdf, World Health Organization Reports, last accessed October 2002.
3. Hooker S.C. J. Am. Chem. Soc. 58:1936;1181-1190.
4. Fieser L.F., Heyman H. J. Biol. Chem. 176:1948;1363-1370.
5. Fieser L.F., Richardson A.P. J. Am. Chem. Soc. 70:1948;3156.
6. Fieser L.F., Berliner E., Bondhus F.J., Chang F.C., Dauben W.G., Ettlinger M.G., Fawaz G., Fields M., Fieser M., Heidelberger C., Heyman H., Selingman A.M., Vaghan W.R., Wilson A.G., Wu M.I., Leffler M.T., Hamlin K.E., Hathaway R.J., Matson E.J., Moore E.E., Moore M.B., Rapla R.T., Zaugg H.E. J. Am. Chem. Soc. 70:1948;3151-3244.
7. Fieser L.F., Heyman H., Selingman A.M. J. Pharmacol. Exp. Ther. 94:1948;112-124.
8. Fieser L.F., Chang F.C., Dauben W.G., Heidelberger C., Heyman H., Selingman A.M. J. Pharmacol. Exp. Ther. 94:1948;85-96.
9. Fieser L.F., Schirmer J.P., Archer A., Lorenz R.R., Pfaffenbatch P.I. J. Med. Chem. 10:1967;513-517.
10. Fieser L.F., Nazer M.Z., Archer S., Berberian D.A., Slighter R.G. J. Med. Chem. 10:1967;517-521.
11. J.G. Olenick, in: Hahn F.E. (Ed.), Mechanism of Action of Antieukaryotic and Antiviral Compounds, Vol. 2, Springer, Berlin, Hiedelberg, New York, 1979, pp. 214-222.
12. A.T. Hudson, in: W. Peters, W.H.G. Richardson (Eds.), Handbook of Experimental Pharmacology, Vol. 68, Part II, Springer, Berlin, Heidelberg, New York, 1984, pp. 343-361.
13. Hudson A.T., Pether M.J., Randall A.W. Eur. J. Med. Chem.-Chim. Ther. 21:1986;271-275.
14. Hudson A.T., Dickins M., Ginger C.D., Gutteridge W.E., Holditch T., Hutchinson D.B.A., Pudney M., Randall A.W., Latter V.S. Drug. Exp. Clin. Res. 9:1991;427-435.
15. McHardy N., Wekesa L.S., Hudson A.T., Randall A.W. Res. Vet. Sci. 39:1985;29-33.
16. Fry M., Pudney M. Biochem. Pharmacol. 43:1992;1545-1553.
17. Fry M., Hudson A.T., Randall A.W., Williams R.B. Biochem. Pharmacol. 33:1984;2115-2122.
18. Martin Y., Bustard T.M., Lynn K.R. J. Med. Chem. 16:1973;1089-1093.
19. Bodini M.E., Bravo P.E., Veronica A.M. Polyhedron. 13:1994;497-503.
20. Perrin D.D., Armarego W.L.F. Purification of Laboratory Chemicals. 1988;Pergamon Press, New York.
21. Sheldrick G.M. SHEXTL-NT v5.1. 1997;Bruker AXS, Madison, WI.
22. Desjardins R.E., Canfield C.J., Haynes J.D., Chulay J.D. Antimicrob. Agents Chemother. 16:1979;710.
23. Mosmann T. J. Immunol. Methods. 65:1983;55.
24. Ren H., Grady S., Gammenara D., Heinzen H., Moyna P., Croft S., Kendrick H., Yardley V., Moyna G. Bioorg. Med. Chem. Lett. 11:2001;1851-1854.
25. Peters J.H., Portus B.L. Ann. Trop. Med. Parasitol. 69:1975;155.
26. Gaultier J., Hauw C. Acta Crystallogr. 19:1965;919-926.
27. Larsen I., Anderson L., Pederson B. Acta Crystallogr. C. 48:1992;2009-2013.
28. Garge P., Chikate R., Padhye S., Savariault J.M., deLoth P., Tuchagues J.P. Inorg. Chem. 29:1990;3315-3320.
29. M.P. Mulay, P.L. Garge, S.B. Padhye, R.C. Haltiwanger, L.A. deLearie, C. Pierpont, J. Chem. Soc., Chem. Commun. (1987) 581-582.
30. Buchanan R.M., Kessel S.C., Downs H.H., Pierpont C.G., Hendrickson D.N. J. Am. Chem. Soc. 100:1978;7894-7900.
31. Buchanan R.M., Pierpont C.G. J. Chem. Soc. 102:1980;4921-4957.
32. Thompson R. Naturally Occurring Quinones. 2nd Edition:1971;Academic Press.
33. Hathaway B.J. Wilkinson G., Gillard R., McCleverty J. Comprehensive Coordination Chemistry. 1987;Pergamon Press, Oxford.
34. Jones R., Summerville D., Basolo F. Chem. Rev. 79:1979;139.
35. R.D. Dowsing, J.F. Gibson, M. Goodgame, P.J. Hayward, J. Chem. Soc. A (1969) 1242.
36. Buchanan R.M., Pierpont C.G. Coord. Chem. Rev. 38:1981;45-87.
37. M. Kwiatkowski, G. Bandoli, J. Chem. Soc., Dalton Trans. (1992) 379-384.
38. Itoh S., Kawakami H., Fukuzumi S. J. Am. Chem. Soc. 120:1998;7271-7277.